A trio of new studies published in JAMA Internal Medicine on Tuesday examining the efficacy of an arthritis drug against Covid-19 showed inconsistent results. Tocilizumab has been used by doctors since the start of the pandemic with the hope of tamping down an abnormal immune response known as a “cytokine storm” that causes severe organ … Continued
The average turnaround time for COVID-19 nasal swab tests decreased from an average of 4 days in April to 2.7 days in September, according to the latest survey results of an ongoing national survey of attitudes about COVID-19. Despite the quicker testing speeds, the results are still too slow in most cases to support successful … Continued
It is becoming increasingly clear that COVID-19 affects the nervous system along with the respiratory system. New research is now suggesting that there may be long-term neurologic consequences in those who survive COVID infections, including more than seven million Americans and another 27 million people worldwide. Particularly troubling is increasing evidence that there may be … Continued
Testing for COVID-19 is a crucial part of keeping people safe and stopping the spread of the virus. But doing so is often a complicated process. Now, a new test by MIT and colleagues promises to make testing so cheap and effective that people could potentially do it every day. Researchers at MIT and the … Continued
If you’re unfortunate enough to be admitted to the hospital with COVID-19, a common blood marker may predict how severe your illness might become, new research shows. The new study was published online Sept. 23 in JAMA Network Open and was led by Dr. John Higgins, a pathologist investigator at the hospital and associate professor … Continued
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic. The new test, known as STOPCovid, is still in the research stage but, in principle, could be made cheaply enough that people could test themselves every day.
New research suggests that COVID-19 is far from benign when it strikes young adults: Once they are hospitalized, 1 in 5 wind up in the ICU and many need ongoing medical care even after they are free of the virus, scientists report. The Harvard University doctors reviewed more than 3,200 coronavirus cases where adults aged … Continued
NPR`s Lulu Garcia-Navarro speaks to Harvard researcher Dr. Jose Figueroa about how COVID-19 disproportionately impacts Black and Latino communities, and how policy makers could address those issues.
Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found. Tuesday’s report, from tests on more than 30,000 people in Iceland, is the most extensive work yet on the immune system’s response to the virus over … Continued
Michelle Williams, Dean of Harvard’s T.H. Chan School of Public Health, joins CNBC’s “Squawk Box” for a closer look at how schools are grappling with how to safely reopen.